Trust CO Of Vermont Sorrento Therapeutics, Inc. Transaction History

Trust CO Of Vermont

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$1.24 - $2.33 $252 - $475	204 New	204 $0
Q1 2022 Apr 05, 2022	SELL	$2.0 - $4.9 $408 - $999	-204 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$4.65 - $7.23 $948 - $1,474	204 New	204 $1,000
Q3 2021 Oct 22, 2021	SELL	$7.41 - $10.99 $1,511 - $2,241	-204 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$6.17 - $18.82 $1,258 - $3,839	204 New	204 $2,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.